Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-13-037283
Filing Date
2013-06-28
Accepted
2013-06-28 17:26:13
Documents
12
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v346913_10k.htm 10-K 693230
2 EXHIBIT 31.1 v346913_ex31-1.htm EX-31.1 9964
3 EXHIBIT 31.2 v346913_ex31-2.htm EX-31.2 10109
4 EXHIBIT 32.1 v346913_ex32-1.htm EX-32.1 4447
5 EXHIBIT 32.2 v346913_ex32-2.htm EX-32.2 4466
6 GRAPHIC image_006.jpg GRAPHIC 25583
  Complete submission text file 0001144204-13-037283.txt   6110522

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT tglp-20130331.xml EX-101.INS 498858
8 XBRL TAXONOMY EXTENSION SCHEMA tglp-20130331.xsd EX-101.SCH 38828
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tglp-20130331_cal.xml EX-101.CAL 43299
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tglp-20130331_def.xml EX-101.DEF 182809
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE tglp-20130331_lab.xml EX-101.LAB 301013
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tglp-20130331_pre.xml EX-101.PRE 231957
Mailing Address 125 MAIDEN LANE, SUITE 309 NEW YORK NY 10038
Business Address 125 MAIDEN LANE, SUITE 309 NEW YORK NY 10038 212-797-9877
Tongli Pharmaceuticals (USA), Inc. (Filer) CIK: 0001052284 (see all company filings)

EIN.: 841090791 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52954 | Film No.: 13941963
SIC: 2834 Pharmaceutical Preparations